Literature DB >> 19712766

Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system.

Anna P Durbin1, Rosanna Setse, Saad B Omer, James G Palmer, Jeffrey A Spaeder, Judy Baker, Frances Lessans, Neal A Halsey.   

Abstract

TeleWatch is an automated telephone/Internet-based system that collects medical product adverse event reports in real-time through an algorithm driven by the patient. 1341 patients, who received yellow fever vaccine and were recruited through 15 travel clinics, contacted the system within 48h of vaccination and 765 (57%) made follow-up contacts. Participation rates were higher among females and persons older than 60 years of age. TeleWatch can be expanded for use in large campaigns involving influenza or other vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19712766     DOI: 10.1016/j.vaccine.2009.08.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Telephone monitoring of adverse events during an MF59®-adjuvanted H5N1 influenza vaccination campaign in Taiwan.

Authors:  Wan-Ting Huang; Chih-Hsi Chang; Mei-Chen Peng
Journal:  Hum Vaccin Immunother       Date:  2013-10-08       Impact factor: 3.452

2.  Active assessment of adverse events following yellow fever vaccination of persons aged 60 years and more.

Authors:  Karina Takesaki Miyaji; André Machado Luiz; Amanda Nazareth Lara; Tania do Socorro Souza Chaves; Roberta de Oliveira Piorelli; Marta Heloisa Lopes; Ana Marli Christovam Sartori
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

3.  Safety of yellow fever vaccine in Indian travellers: A prospective observational study.

Authors:  Pramil Tiwari; Rajiv Ahlawat; Gaurav Gupta
Journal:  Indian J Med Res       Date:  2016-11       Impact factor: 2.375

Review 4.  Yellow fever vaccine and risk of developing serious adverse events: a systematic review.

Authors:  Ruben Porudominsky; Eduardo H Gotuzzo
Journal:  Rev Panam Salud Publica       Date:  2018-06-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.